A phase II trial of SENS-401 to treat sudden deafness in a pediatric population
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2018
At a glance
- Drugs Arazasetron (Primary)
- Indications Hearing loss
- Focus Proof of concept; Therapeutic Use
- Sponsors Sensorion
- 29 Jun 2018 According to a Sensorion media release, This trial is expected to begin in the coming weeks.
- 12 Apr 2018 According to a Sensorion media release, an interim analysis of results shall be available in mid-2019.
- 21 Oct 2017 New trial record